Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)

China · Delayed Price · Currency is CNY

6.11

+0.03 (0.49%)

Sep 30, 2026, 3:04 PM CST

Market Cap	2.84B -5.7%
Revenue (ttm)	3.50B -12.5%
Net Income	94.42M -31.0%
EPS	0.20 -31.0%
Shares Out	464.69M
PE Ratio	30.07
Forward PE	n/a
Dividend	0.10 (1.64%)
Ex-Dividend Date	Jun 18, 2026

Volume	7,456,660
Open	6.16
Previous Close	6.08
Day's Range	6.08 - 6.17
52-Week Range	4.95 - 7.35
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:000153

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1997

Employees 4,278

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 000153

Full Company Profile

Financial Performance

In 2025, SHE:000153's revenue was 3.86 billion, a decrease of -9.95% compared to the previous year's 4.28 billion. Earnings were 99.42 million, a decrease of -38.19%.

Financial Statements